Abbott Nutrition reached an agreement with FDA to reopen its infant formula plant amid the ongoing shortage, in today's bite-sized hospital and health industry news from Illinois, Michigan, and Tennessee.
- Illinois: Abbott Nutrition on Monday announced that it reached an agreement with FDA to resume operations at its infant formula plant in Michigan after the facility was shut down over an FDA recall—a deal that was made after an investigation between Abbott, FDA, and CDC found "no conclusive evidence to link Abbott's formulas to these infant illnesses." The company will be allowed to resume the plant's operations in two weeks. According to the company, the infant formula should be available in stores six to eight weeks after their Michigan facility reopens. "Our No. 1 priority is getting infants and families the high-quality formulas they need, and this is a major step toward re-opening our Sturgis facility so we can ease the nationwide formula shortage," said Robert Ford, chairman and CEO of Abbott. "We look forward to working with the FDA to quickly and safely re-open the facility. We know millions of parents and caregivers depend on us and we're deeply sorry that our voluntary recall worsened the nationwide formula shortage. We will work hard to re-earn the trust that moms, dads and caregivers have placed in our formulas for more than 50 years." (Scribner, Axios, 5/16)
- Michigan: Gov. Gretchen Whitmer (D) signed a bill that gives full practice authority to certified registered nurse anesthetists (CRNAs), making Michigan the 20th state to opt out of federal regulations that require physician supervision of CRNAs. "Removing barriers to CRNA practice allows Michigan hospitals to select the anesthesia delivery model that maximizes their workforce and increases access to safe, affordable care for all patients," said former Michigan Association of Nurse Anesthetists president Toni Schmittling. "By signing this important legislation, Michigan recognizes that CRNAs are qualified to make decisions regarding all aspects of anesthesia care based on their education, licensure, and certification." (Gooch, Becker's Hospital Review, 5/13)
- Tennessee: HCA Healthcare on Friday named Keith Zimmerman president of its MidAmerica division, effective June 13. Zimmerman, who brings more than 30 years of experience to the role, will oversee seven HCA hospitals around Kansas City, Kansas. He previously served as CEO of Medical City Arlington and led Medical City Children's Hospital in Dallas. Zimmerman succeeds Mel Lagarde, who decided to retire after four decades with the health system. (Gooch, Becker's Hospital Review, 5/13)